Zheng H, Wu L, Chen J, Na N, et al. Neoadjuvant nivolumab plus bevacizumab therapy improves the prognosis of triple-negative breast cancer in humanized mouse models. Breast Cancer 2024 Jan 30. doi: 10.1007/s12282-024-01543.
PMID: 38289410